A Tursi

Summary

Country: Italy

Publications

  1. ncbi Detection of endoscopic and histological inflammation after an attack of colonic diverticulitis is associated with higher diverticulitis recurrence
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Via Torino 49, 76123 Andria, BT, Italy
    J Gastrointestin Liver Dis 22:13-9. 2013
  2. ncbi Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence
    A Tursi
    Gastroenterology Service, ASL BAT, Andria, Barletta, Italy
    Eur Rev Med Pharmacol Sci 17:342-8. 2013
  3. ncbi Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study
    A Tursi
    Gastroenterology Service, ASL BAT, Andria Bt, Italy
    Neurogastroenterol Motil 24:836-e396. 2012
  4. ncbi Biomarkers in diverticular diseases of the colon
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Andria, Italy
    Dig Dis 30:12-8. 2012
  5. ncbi Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection
    Antonio Tursi
    Gastroenterology Service Territoriale, ASL BAT, Andria Bt, Italy
    J Gastrointestin Liver Dis 21:133-8. 2012
  6. ncbi Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity
    A Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Andria Bt, Italy
    Colorectal Dis 14:e258-63. 2012
  7. ncbi Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Int J Colorectal Dis 22:1103-8. 2007
  8. ncbi Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Med Sci Monit 13:CR187-90. 2007
  9. ncbi Gastric outlet obstruction due to gastroduodenal eosinophilic gastroenteritis
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria (BA, Italy
    Endoscopy 39:E184. 2007
  10. ncbi The clinical picture of uncomplicated versus complicated diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Via Torino 49, Andria, BA, Italy
    Dig Dis Sci 53:2474-9. 2008

Collaborators

Detail Information

Publications95

  1. ncbi Detection of endoscopic and histological inflammation after an attack of colonic diverticulitis is associated with higher diverticulitis recurrence
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Via Torino 49, 76123 Andria, BT, Italy
    J Gastrointestin Liver Dis 22:13-9. 2013
    ..The aim of our study was to investigate the role of endoscopic and histological inflammation as predictors for the recurrence of diverticulitis...
  2. ncbi Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence
    A Tursi
    Gastroenterology Service, ASL BAT, Andria, Barletta, Italy
    Eur Rev Med Pharmacol Sci 17:342-8. 2013
    ..Colonic diverticulitis shows a high recurrence rate...
  3. ncbi Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study
    A Tursi
    Gastroenterology Service, ASL BAT, Andria Bt, Italy
    Neurogastroenterol Motil 24:836-e396. 2012
    ..We assessed the mucosal expression of bFGF, SD1, and TNF-α in DD according to the severity of the disease. Moreover, we assessed the response to therapy of these cytokines in acute uncomplicated diverticulitis (AUD)...
  4. ncbi Biomarkers in diverticular diseases of the colon
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Andria, Italy
    Dig Dis 30:12-8. 2012
    ..In fact, FC values decreased significantly in patients responding to therapy, whereas they persisted to increase in patients who failed to obtain remission...
  5. ncbi Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection
    Antonio Tursi
    Gastroenterology Service Territoriale, ASL BAT, Andria Bt, Italy
    J Gastrointestin Liver Dis 21:133-8. 2012
    ..pylori is a frequent occurrence. We assessed the effectiveness of a third-line, levofloxacin-containing, 10-day sequential treatment, in order to obtain eradication of H. pylori resistant patients in a clinical setting...
  6. ncbi Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity
    A Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Andria Bt, Italy
    Colorectal Dis 14:e258-63. 2012
    ..The aim of this study was to assess TNF-α expression in DD and to see whether it is related to the severity of the disease...
  7. ncbi Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Int J Colorectal Dis 22:1103-8. 2007
    ..The role of probiotics in the treatment of diverticulitis is still not known. The aim of our study was to investigate whether balsalazide and/or VSL#3 is effective in preventing diverticulitis recurrence...
  8. ncbi Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Med Sci Monit 13:CR187-90. 2007
    ..pylori-positive patients remain infected after a first eradication attempt. Lactoferrin, a natural anti-bacterial glycoprotein, seems a promising tool in treating H. pylori infection, but it has never been used in second-line treatment...
  9. ncbi Gastric outlet obstruction due to gastroduodenal eosinophilic gastroenteritis
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria (BA, Italy
    Endoscopy 39:E184. 2007
  10. ncbi The clinical picture of uncomplicated versus complicated diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Via Torino 49, Andria, BA, Italy
    Dig Dis Sci 53:2474-9. 2008
    ..6 years, range 47-75 years) were studied. Symptoms, the inflammatory indices, and Computerized Tomography (CT) scan of the abdomen were assessed at the time of admission...
  11. ncbi Assessment and grading of mucosal inflammation in colonic diverticular disease
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, BA, Italy
    J Clin Gastroenterol 42:699-703. 2008
    ..The aim of this study was to assess and grade the mucosal inflammatory infiltrate in different degrees of diverticular disease (DD) and to compare them with healthy matched controls...
  12. ncbi Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages
    Antonio Tursi
    Lorenzo Bonomo Hospital, Via Torino, 49, 70031, Andria, BA, Italy
    Dig Dis Sci 53:2925-8. 2008
    ..were excluded. All patients were started on a gluten-free diet and were reassessed throughout a long-term follow-up period to evaluate the outcome of pregnancy...
  13. ncbi Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Via Torino, 49, 70031 Andria, BA, Italy
    Dig Liver Dis 40:737-42. 2008
    ..Increased epithelial cell proliferation may be detected in diverticular disease, but antibiotics have failed in reducing it. We assess therefore the effect of mesalazine on epithelial cell proliferation in diverticular disease...
  14. ncbi New physiopathological and therapeutic approaches to diverticular disease of the colon
    Antonio Tursi
    Lorenzo Bonomo Hospital, Digestive Endoscopy Unit, Via Torino, 49, 70031 Andria, BA, Italy
    Expert Opin Pharmacother 8:299-307. 2007
    ....
  15. ncbi Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Galleria Pisani, 4, Andria, BA, Italy
    Dig Dis Sci 52:671-4. 2007
    ..56%) and 5 in group B (31.25%; P < 0.005; overall symptomatic score, 68). Daily mesalazine supplying seems to be more effective than cyclic supplying in maintaining remission in recurrent symptomatic uncomplicated diverticular disease...
  16. ncbi High prevalence of celiac disease among patients affected by Crohn's disease
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, Italy
    Inflamm Bowel Dis 11:662-6. 2005
    ..Our aim was to evaluate the prevalence of celiac disease in a consecutive series of patients affected by CD, in whom the disease was diagnosed for the first time...
  17. ncbi Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Dig Dis Sci 51:461-5. 2006
    ..In conclusion, most pts affected by symptomatic uncomplicated diverticular disease of the colon showed LM, and in more than 70% of cases it disappeared after successful treatment of the colonic disease...
  18. ncbi Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, BA, Italy
    J Clin Gastroenterol 40:312-6. 2006
    ..To investigate the effectiveness and safety of mesalazine, with or without Lactobacillus casei, in preventing recurrence of symptomatic diverticular disease of the colon...
  19. ncbi Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Med Sci Monit 12:PI29-32. 2006
    ..Budesonide is a steroid with low systemic effect and high effectiveness in the treatment of Crohn's Disease (CD). Beclomethasone dipropionate (BDP) is also a steroid with the same systemic effects, but it has been never investigated in CD...
  20. ncbi Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, Italy
    Endoscopy 38:702-7. 2006
    ..We conducted a 2-year prospective study to evaluate the effectiveness of a GFD in improving the endoscopic and histological duodenal findings in adults with celiac disease...
  21. ncbi Crohn's disease and celiac disease: association or epiphenomenon?
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, BA, Italy
    Eur Rev Med Pharmacol Sci 10:127-30. 2006
    ..Recent literature data show a certain relation between Crohn's disease and celiac disease. We describe herein what are the pro and the cons about a possible association between Crohn's disease and celiac disease...
  22. ncbi Peripheral neurological disturbances, autonomic dysfunction, and antineuronal antibodies in adult celiac disease before and after a gluten-free diet
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, BA, Italy
    Dig Dis Sci 51:1869-74. 2006
    ..We conclude that adult CD patients may show neurological damage and presence of antineuronal antibodies. Unfortunately, these findings do not disappear with a GFD...
  23. ncbi Synchronous gastric and colonic MALT-lymphoma in coeliac disease: a long-term follow-up on gluten-free diet
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Dig Liver Dis 39:1035-8. 2007
    ....
  24. ncbi Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, Italy
    Hepatogastroenterology 55:916-20. 2008
    ..Four different therapeutic schedules with mesalazine and/or probiotics were assessed in preventing recurrence of symptomatic diverticular disease (DD) of the colon...
  25. ncbi Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    J Clin Gastroenterol 42:S119-22. 2008
    ..In this paper, the framework for using this association to treat ulcerative colitis or to prevent the recurrence of colonic diverticulitis is reviewed, and 2 studies on this therapeutic approach are briefly summarized...
  26. ncbi [Perspectives in the treatment of the diverticular disease of the colon]
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, Torino
    Recenti Prog Med 102:380-6. 2011
    ..These new informations have permitted new therapeutic approaches. We reviewed the current and novel therapeutic indications in order to treat the symptoms and preventing recurrence...
  27. ncbi Segmental colitis associated with diverticulosis: a 5-year follow-up
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Andria BAT, Italy
    Int J Colorectal Dis 27:179-85. 2012
    ..Literature data about the outcome of segmental colitis associated with diverticulosis (SCAD) are scarce. Our aim was to assess the clinical outcome of SCAD according to the type of disease...
  28. ncbi Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis
    A Tursi
    Gastroenterology Service, Andria, Barletta Andria Trani, Italy
    Minerva Gastroenterol Dietol 57:247-55. 2011
    ..Moreover, we compared FC levels in different degrees of SCAD and assessed FC SCAD before and after treatment...
  29. ncbi Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Via Torino, 49, 76123 Andria, BT, Italy
    Dig Dis Sci 56:3112-21. 2011
    ..Further randomized, well-controlled studies are required for validation; however, it seems that mesalamine is an important agent in future diverticular disease management...
  30. ncbi Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Andria BAT, Italy
    Dig Liver Dis 43:374-9. 2011
    ..Tumour necrosis factor-α expression may be increased in segmental colitis associated with diverticulosis...
  31. ncbi Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease
    A Tursi
    ASL BAT, Andria, Bari, Italy
    Aliment Pharmacol Ther 33:358-65. 2011
    ....
  32. ncbi Prevalence of celiac disease and symptoms in relatives of patients with celiac disease
    A Tursi
    Gastroenterology Service, ASL BAT, Andria BAT, Italy
    Eur Rev Med Pharmacol Sci 14:567-72. 2010
    ..We determined the prevalence and clinical features of celiac disease (CD) in family-members (FMs) of a population-based cohort of index cases...
  33. ncbi Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study
    Antonio Tursi
    Lorenzo Bonomo Hospital, Andria, Italy
    Am J Gastroenterol 105:2218-27. 2010
    ....
  34. ncbi Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Andria, Italy
    J Clin Gastroenterol 44:702-6. 2010
    ..Acute uncomplicated diverticulitis (AUD) may show histologic and serologic signs of inflammation...
  35. ncbi Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, ASL BAT, Via Torino, 49, 70031, Andria, Italy
    Dig Dis Sci 56:27-34. 2011
    ..We therefore describe herein current knowledge about this disease, and why it can be considered a truly autonomous entity instead of a complication of diverticular disease...
  36. ncbi Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice
    A Tursi
    Division of Gastroenterology, Michele Sarcone Hospital, Terlizzi, Bari, Italy
    Eur Rev Med Pharmacol Sci 14:47-55. 2010
    ..Our aim was to assess the efficacy and safety of infliximab (IFX) in clinical practice in three Primary Care, Hospital Centers...
  37. ncbi Balsalazide in treating colonic diseases
    Antonio Tursi
    Servizio di Gastroenterologia Territoriale, DSS n 4, ASL BAT, Via Torino, 49, Andria, Italy
    Expert Opin Drug Metab Toxicol 5:1555-63. 2009
    ..Finally, there is also some recent evidence that balsalazide may be effectively used, in combination with probiotics, in treating acute uncomplicated diverticulitis is the colon...
  38. ncbi The endoscopic spectrum of segmental colitis associated with diverticulosis
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Colorectal Dis 12:464-70. 2010
    ..An endoscopic classification of 'Segmental colitis associated with diverticulosis' (SCAD) is lacking. Our aim was therefore to assess the endoscopic spectrum of SCAD, comparing it with the histological and clinical features...
  39. ncbi Review article: the current and evolving treatment of colonic diverticular disease
    A Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, Italy
    Aliment Pharmacol Ther 30:532-46. 2009
    ..Diverticular disease can be associated with numerous debilitating abdominal and gastrointestinal symptoms (including pain, bloating, nausea, constipation and diarrhoea)...
  40. ncbi Complications in celiac disease under gluten-free diet
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, 49 70031 Andria, BA, Italy
    Dig Dis Sci 54:2175-82. 2009
    ..s.). Less than 5% of CD patients may develop complications under GFD. Complications seem to affect more classical CD than subclinical CD, and seem to be irrespective of optimal GFD adherence...
  41. ncbi Faecal calprotectin in colonic diverticular disease: a case-control study
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Via Torino, 49, 70031, Andria, BA, Italy
    Int J Colorectal Dis 24:49-55. 2009
    ..We assessed FC in colonic DD, comparing it with irritable bowel syndrome (IBS) patients and healthy controls. Moreover, we compared FC levels in different degrees of DD and assessed FC in symptomatic DD before and after treatment...
  42. ncbi Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Andria, BT, Italy
    J Gastrointestin Liver Dis 20:365-70. 2011
    ..Tumour necrosis factor-α (TNF-α) expression may be increased in segmental colitis associated with diverticulosis (SCAD). Our aim was to assess TNF-α expression in SCAD in relationship to the treatment...
  43. ncbi Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Galleria Pisani 4, 70031 Andria, Italy
    World J Gastroenterol 11:2773-6. 2005
    ..Acute diverticulitis is affected by some similar symptoms and bacterial colonic overgrowth. We assessed the prevalence of SIBO in acute uncomplicated diverticulitis and evaluated its influence on the clinical course of the disease...
  44. ncbi Acute diverticulitis of the colon--current medical therapeutic management
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Galleria Pisani, 4 70031 Andria BA, Italy
    Expert Opin Pharmacother 5:55-9. 2004
    ....
  45. ncbi Effectiveness of the sorbitol H2 breath test in detecting histological damage among relatives of coeliacs
    A Tursi
    Dept of Emergency, L Bonomo Hospital, Andria BA, Italy
    Scand J Gastroenterol 38:727-31. 2003
    ....
  46. ncbi Sorbitol H2-breath test versus anti-endomysium antibodies to assess histological recovery after gluten-free diet in coeliac disease
    A Tursi
    Emergency Department L Bonomo Hospital, Andria, BA, Italy
    Dig Liver Dis 34:846-50. 2002
    ..Gluten-free diet plays a key role in treatment of coeliac disease, but it is difficult to evaluate its effect on improvement of villous architecture using sensitive non-invasive tests...
  47. ncbi Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease
    Antonio Tursi
    Department of Emergency, L Bonomo Hospital, Andria, Italy
    J Clin Gastroenterol 36:219-21. 2003
    ....
  48. ncbi Gastrointestinal motility disturbances in celiac disease
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    J Clin Gastroenterol 38:642-5. 2004
    ....
  49. ncbi Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy
    Antonio Tursi
    Department of Emergency, L Bonomo Hospital, Andria, Cristo Re Hospital, Rome, Italy
    Eur J Gastroenterol Hepatol 15:69-74. 2003
    ..Because slow-release drug formulations are increasingly available for the treatment, there is a concrete risk that delayed OCTT may impair the efficacy of these formulations...
  50. ncbi Endoscopic features of celiac disease in adults and their correlation with age, histological damage, and clinical form of the disease
    A Tursi
    Emergency Department, L Bonomo Hospital, Andria BA, Italy
    Endoscopy 34:787-92. 2002
    ....
  51. ncbi Efficacy, tolerability, and factors affecting the efficacy of the sequential therapy in curing Helicobacter pylori infection in clinical setting
    Antonio Tursi
    Gastroenterology Service, ASL BAT, Andria BAT, Italy
    J Investig Med 59:917-20. 2011
    ..We evaluated the efficacy of this therapy regimen in our current clinical practice...
  52. ncbi Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy
    Antonio Tursi
    Digestive Endoscopy Unit, L Bonomo Hospital, Andria, Bari, Italy
    J Clin Gastroenterol 38:360-3. 2004
    ....
  53. ncbi Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Med Sci Monit 10:PI126-31. 2004
    ..25 g/day) plus 3 g/day VLS#3 (group A) with medium-dose balsalazide alone (group B) and with mesalazine (group C) in the treatment of mild-to-moderate active ulcerative colitis...
  54. ncbi Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection
    Antonio Tursi
    Division of Emergency, L Bonomo Hospital, Andria, Italy
    Hepatogastroenterology 49:1006-9. 2002
    ..The aim of this study was to compare the efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure H. pylori infection...
  55. ncbi Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria BA, Italy
    Med Sci Monit 10:CR662-6. 2004
    ..Probiotics have never been used as second-line treatment in patients resistant to a first course of anti-H. pylori treatment...
  56. ncbi Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease
    Antonio Tursi
    Department of Emergency, L Bonomo Hospital, Andria, Italy
    J Clin Gastroenterol 37:387-91. 2003
    ..Anti-tTG does not seem effective to assess histologic recovery in the follow-up of celiac patients after they have started GFD due to its poor correlation with histologic damage...
  57. ncbi Mesalazine for diverticular disease of the colon--a new role for an old drug
    Antonio Tursi
    Lorenzo Bonomo Hospital, Digestive Endoscopy Unit, Andria BA, Italy
    Expert Opin Pharmacother 6:69-74. 2005
    ..More-over, in light of some preliminary results, it is probable that the association of mesalazine with probiotics may in the future be the first-choice treatment for mild-to-moderate uncomplicated attacks of acute diverticulitis...
  58. ncbi Sodium benzoate-induced repeated episodes of acute urticaria/angio-oedema: randomized controlled trial
    E Nettis
    Department of Medical Clinics, Immunology and Infectious Diseases, Section of Allergy and Clinical Immunology, University of Bari, Cattedra di Allergologia e Immunologia Clinica, Padiglione Chini Policlinico, Bari, Italy
    Br J Dermatol 151:898-902. 2004
    ..Numerous cases of adverse reactions to benzoate have been recorded, but most of the studies that have been conducted lacked proper placebo controls or blinding...
  59. ncbi Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon
    A Tursi
    Emergency Division, L Bonomo Hospital, Andria BA, Italy
    Dig Liver Dis 34:510-5. 2002
    ....
  60. ncbi Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease
    A Tursi
    Division of Internal Medicine, Umberto I Hospital, Barletta, Italy
    Am J Gastroenterol 96:1507-10. 2001
    ....
  61. ncbi Suspected tartrazine-induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge
    E Nettis
    Department of Medical Clinic, Immunology and Infectious Diseases, Section of Allergy and Clinical Immunology, University of Bari, Bari, Italy
    Clin Exp Allergy 33:1725-9. 2003
    ..Tartrazine has been frequently linked to several diseases. However, a cause-and-effect role for tartrazine in these illnesses, especially in urticaria, has not always been established...
  62. ncbi Sorbitol H2-breath test versus anti-endomysium antibodies for the diagnosis of subclinical/silent coeliac disease
    A Tursi
    Division of Emergency, L Bonomo Hospital, Andria BA, Italy
    Scand J Gastroenterol 36:1170-2. 2001
    ....
  63. ncbi Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation
    A Tursi
    Division of Internal Medicine, Ospedale Civile Umberto I, Barletta, BA, Italy
    Hepatogastroenterology 48:462-4. 2001
    ..However, a more precise description of subclinical/silent celiac disease can only emerge from screening studies on general populations...
  64. ncbi Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study
    E Nettis
    Department of Clinical Medicine, Immunology and Infectious Deseases, University of Bari, Bari, Italy
    Br J Dermatol 156:674-81. 2007
    ..Natural rubber latex (NRL) allergy is a worldwide problem. Although prevention is sufficient to reduce sensitization, prolonged avoidance is needed to prevent resensitization or adverse reactions on re-exposure...
  65. ncbi Immune tolerance to drugs. I. Long-term tolerability of rokitamycin in patients with antibiotics hypersensitivity
    E Nettis
    Department of Internal Medicine, Immunology and Infectious Diseases, Section of Allergy and Clinical Immunology, University of Bari, Bari, Italy
    Immunopharmacol Immunotoxicol 25:365-75. 2003
    ..This study, points out a low percentage of adverse reactions to rokitamycin after a negative challenge test, thus, emphasizing both safety and good predictive value as a challenge test...
  66. ncbi Immune tolerance to drugs. (II).: Long-term tolerability of nimesulide in patients with NSAID hypersensitivity
    E Nettis
    Department of Internal Medicine, Immunology and Infectious Diseases Section of Allergy and Clinical Immunology, University of Bari, Bari, Italy
    Immunopharmacol Immunotoxicol 26:469-80. 2004
    ..In patients with the above risk factors, a prior tolerance test with a selective COX2 antagonist should be administered...
  67. ncbi High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal
    Antonio Tursi
    Department of Emergency, L. Bonomo Hospital, Andria (BA, Italy
    Am J Gastroenterol 98:839-43. 2003
    ..CONCLUSIONS: This study showed that SIBO affects most celiacs with persistence of GI symptoms after gluten withdrawal...
  68. ncbi Allergic reactions to inhalant glucocorticosteroids: a hot topic for pneumologists and allergologists
    E Nettis
    Department of Internal Medicine, Immunology and Infectious Diseases, Section of Allergy and Clinical Immunology, University of Bari, Bari, Italy
    Immunopharmacol Immunotoxicol 28:511-34. 2006
    ..In fact, this particular form of sensitization to drugs that have a wide spectrum of use in pneumological practice deserves more attention than in the past...
  69. ncbi Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease
    Giovanni Brandimarte
    Department of Internal Medicine, Division of Gastroenterology, Cristo Re Hospital, Rome, Italy
    Med Sci Monit 10:PI70-3. 2004
    ..CONCLUSIONS: The results show that rifaximin/mesalazine followed by mesalazine alone is extremely effective in resolving symptoms in patients with symptomatic uncomplicated diverticular disease...
  70. ncbi Contact dermatitis in students practicing sports: incidence of rubber sensitisation
    M T Ventura
    Department of Internal Medicine, Immunology and Infectious Disease, University of Bari Medical School, Policlinico, Bari, Italy
    Br J Sports Med 35:100-2. 2001
    ....
  71. ncbi Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference
    A Gasbarrini
    Department of Internal Medicine, Gemelli Hospital, Catholic University, Rome, Italy
    Aliment Pharmacol Ther 29:1-49. 2009
    ..There are many differences in the methodology, and the tests are increasingly popular...
  72. ncbi Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma
    Antonio Tursi
    Department of Emergency Medicine, L Bonomo Hospital, Andria, Italy
    Am J Gastroenterol 97:1802-6. 2002
    ..However, further studies are needed to demonstrate the antigenic role of HCV in the progression of acquired MALT into MALT lymphoma...
  73. ncbi [Celiac disease and irritable bowel syndrome: association or diagnostic error?]
    Antonio Tursi
    Dipartimento di Emergenze, Ospedale Lorenzo Bonomo, Andria, Bari
    Recenti Prog Med 94:75-8. 2003
    ..We described herein which are the arguments pro and cons the association between coeliac disease and irritable bowel syndrome, and which is the correct diagnostic algorithm to perform the correct diagnosis...
  74. ncbi Endoscopic snare excision of large pedunculated colorectal polyps: a new, safe, and effective technique
    G Brandimarte
    Dept. of Internal Medicine, Digestive Endoscopy Unit, Cristo Re Hospital, Rome, Italy
    Endoscopy 33:854-7. 2001
    ..Moreover, this technique is cheaper than the use of the standard detachable snare currently available (the cost of the snares being $50.52 compared with $189.47)...
  75. ncbi The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy
    Antonio Tursi
    Department of Emergency, L Bonomo Hospital, Andria BA, Italy
    J Clin Gastroenterol 36:13-7. 2003
    ..Our aim was to assess the benefit of a gluten-free diet (GFD) in patients with these small bowel mucosal abnormalities...
  76. ncbi Monoclonal gammopathy of undetermined significance predisposing to Helicobacter pylori-related gastric mucosa-associated lymphoid tissue lymphoma
    Antonio Tursi
    Department of Emergency, L Bonomo Hospital, Andria, Italy
    J Clin Gastroenterol 34:147-9. 2002
    ..We report a patient with MGUS and H. pylori infection in whom we noted the progression of gastritis to acquired gastric MALT and gastric MALT to MALT lymphoma during a 3-year follow-up...
  77. ncbi Assessment of autonomic function in untreated adult coeliac disease
    Gian-Marco Giorgetti
    Department of Internal Medicine, Clinical Nutrition Unit, S. Eugenio Hospital, Rome, Italy
    World J Gastroenterol 10:2715-8. 2004
    ..CONCLUSION: This study failed to confirm a significant correlation between autonomic dysfunction and coeliac disease, yet we could not exclude a role of autonomic dysfunction in the genesis of systemic symptoms in some coeliacs...
  78. ncbi Epithelial cell proliferation of the colonic mucosa in different degrees of colonic diverticular disease
    Antonio Tursi
    Digestive Endoscopy Unit, Lorenzo Bonomo Hospital, Andria, BA, Italy
    J Clin Gastroenterol 40:306-11. 2006
    ..In particular, asymptomatic diverticulosis seems to show the same risk for colonic carcinoma as that of UC...
  79. ncbi Endoscopic treatment of benign anastomotic esophageal stenosis with electrocautery
    G Brandimarte
    Department of Internal Medicine, Digestive Endoscopy Unit, Cristo Re Hospital, Rome, Italy
    Endoscopy 34:399-401. 2002
    ..CONCLUSIONS: This study showed that endoscopic electrocautery is a safe and effective treatment for benign anastomotic esophageal stenosis...
  80. ncbi Clinical and aetiological aspects in urticaria and angio-oedema
    E Nettis
    Department of Medical Clinics, Immunology and Infectious Diseases, University of Bari, Piazza Giulio Cesare 11, Policlinico 70124, Bari, Italy
    Br J Dermatol 148:501-6. 2003
    ..Urticaria is a common disorder that affects as many as 20% of all people at some time during their lifetime...
  81. ncbi Immune response in patients with oral lichen planus and HCV infection
    M Petruzzi
    Department of Dentistry and Surgery, University of Bari, Bari, Italy
    Int J Immunopathol Pharmacol 17:93-8. 2004
    ..1 in HCV- and 27% +/- 19.4 in HCV+ patients; p=0.47). These findings suggest the existence of differences in lymphocyte subpopulations between OLP-HCV+ subjects and OLP-HCV- patients...
  82. ncbi Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohn's disease
    Antonio Tursi
    Inflamm Bowel Dis 13:1184-6. 2007
  83. ncbi Onset of Crohn's disease after Helicobacter pylori eradication
    Antonio Tursi
    Inflamm Bowel Dis 12:1008-9. 2006
  84. ncbi Three-hour hydrogen breath test for assessing lactose malabsorption in clinical practice: to give 50 or 20 grams of lactose?
    Antonio Tursi
    Dig Dis Sci 51:138-9. 2006
  85. ncbi Diverticular disease of the colon
    Antonio Tursi
    Lancet 363:1397-8. 2004
  86. ncbi H2 breath tests for the diagnosis of celiac disease
    Antonio Tursi
    Am J Gastroenterol 97:2679-80; author reply 2680. 2002
  87. ncbi Regression of Apo B deficiency in biovular twins with Apo B deficiency and celiac disease after gluten withdrawal
    Giovanni Brandimarte
    Am J Gastroenterol 97:1856-8. 2002
  88. ncbi Preventive therapy for complicated diverticular disease of the colon: looking for a correct therapeutic approach
    Antonio Tursi
    Gastroenterology 127:1865-6. 2004
  89. ncbi Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C
    Antonio Tursi
    Inflamm Bowel Dis 13:1189-90. 2007
  90. ncbi Beclomethasone dipropionate plus VSL#3 for the treatment of mild to moderate diverticular colitis: an open, pilot study
    Antonio Tursi
    J Clin Gastroenterol 39:644-5. 2005
  91. ncbi Factors influencing lactose intolerance
    Antonio Tursi
    Eur J Clin Invest 34:314-5; author reply 316. 2004
  92. ncbi The genetic puzzle of celiac disease
    Antonio Tursi
    Gastroenterology 126:1216-7; author reply 1217. 2004
  93. ncbi Irritable bowel syndrome and coeliac disease
    Antonio Tursi
    Lancet 359:1347. 2002
  94. ncbi The treatment of gastro-esophageal reflux disease in adult celiac disease
    Antonio Tursi
    J Clin Gastroenterol 38:724-6. 2004
  95. ncbi Computed tomographic colonography or conventional colonoscopy in detecting small colonic lesions in clinical practice?
    Antonio Tursi
    Gastroenterology 126:937-8; author reply 938-9. 2004